Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of RO7121661, RO7247669, and Nivolumab for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Not recruiting

    1 1
    Denmark France Hungary Italy Poland Spain
  • Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Ireland +4
  • Study on Tocilizumab for Patients with Esophageal Cancer to Improve Chemoradiotherapy Outcomes

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Activity of S095029 and Pembrolizumab for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark France Hungary Italy +1
  • Study on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study of Durvalumab with Chemotherapy and Radiotherapy for Patients with Unresectable Esophageal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Ireland
  • Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

    Not recruiting

    1 1 1
    Belgium France The Netherlands Spain
  • Study on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

    Not recruiting

    1 1 1
    Belgium Czechia Denmark Estonia France Germany +4